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Special issue: Prion-related disordersDespite the impressive pace of prion research in recent years,
many important issues remain unresolved and new forms of
prion disease continue to emerge. In this special issue of the
BBA–Molecular Basis of Disease series, we have assembled a
combination of important mini-reviews and research papers
from leaders in the field of prion research. The result is a
snapshot that not only summarizes recent progress in the field
but also points to the remaining unresolved issues in prion
biology that will shape future developments.
Although much progress has been made in understanding the
origins and spread of bovine spongiform encephalopathy (BSE),
it will be some years before the full impact on human health can
be predicted with confidence. Jonathan Wadsworth and John
Collinge have been at the forefront of attempts to understand the
relationship between BSE and human prion disease. The
recognition that variant Creutzfeldt–Jakob disease and BSE
are caused by the same prion strain as well as the apparently
protean nature of BSE prions has dramatically highlighted the
need for a precise understanding of the molecular biology of
human and animal prion diseases. The zoonotic potential of BSE
prions highlights the importance of human exposure to prions
from other sources. Of particular concern is the emergence of
chronic wasting disease (CWD) of deer, elk, and moose in North
America. Although BSE and CWD appear to be teleologically
unrelated, the connection of CWD to other animal prion
diseases, in particular scrapie in sheep and goats, remains
obscure. In addition, previously unrecognized forms of scrapie
appear, like CWD, to be emerging. CWD is reviewed by
Christina Sigurdson and Adriano Aguzzi, while Nora Hunter
summarizes the biology of classical and atypical scrapie.
Relevant to the issue of unpredictable interspecies prion
transmission is the issue of prion strains, which remain one of
the most challenging problems for the prion hypothesis. Rodrigo
Morales, Karim Abid, and Claudio Soto review the in vivo and
molecular approaches that illustrate the changeable nature of
prion strains as they transit species barriers.
The physiological function of the normal form of the prion
protein remains unclear and it is uncertain whether loss of this
function contributes to prion pathogenesis. In their review,
Laura Westergard, Heather Christensen, and David Harris
summarize the major proposed functions for PrPC and outline
how loss of neuroprotective PrPC might contribute to prion0925-4439/$ - see front matter © 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbadis.2007.05.007pathogenesis. Along these lines Karah Nazor, Tanya Seward
and I detail the results of new studies that show behavioral and
neuropathological deficits in PrP knockout mice. An increas-
ingly important aspect of prion pathology revolves around
additional prion protein gene family members, namely Doppel,
and the newly described relative, Shadoo, which has over-
lapping functional activity with PrPC. Joel Watts and David
Westaway review studies describing the functional interrela-
tionships of these proteins, the continued study of which will
likely shed light on the function of PrPC and the neurotoxic
pathways that are initiated during prion disease.
Studies involving the manipulation of PrP genes by
transgenesis in mice have provided crucial insights into the
mechanism of prion propagation and the pathogenesis of prion
diseases. Jean Manson and her colleagues describe recent
advances using elegant gene targeting approaches in which
specific mutations have been introduced into the endogenous
murine PrP genes including glycosylation-defective mutants,
pathogenic point mutations, disease modulating polymorph-
isms, and the effects of expressing different primary structures
of PrP from different species on disease susceptibility. In
concert with powerful in vivo approaches to studying prion
diseases, recent years have witnessed the apparent generation of
prion infectivity from PrP synthesized in non-mammalian
systems as well as the development of cell-free systems in
which to study prion conversion. Ilia Baskakov and Leonid
Breydo summarize describe the strategies and challenges
related to the de novo generation of synthetic mammalian
prions, while Leila Kupfer, Martin Groschup, and colleagues
describe the results of new experiments showing that PrP
conversion depends on a combination of PrP amino acid
sequence and prion strain properties.
I extend my warm thanks to the authors, researchers, and
editorial staff who contributed their time and efforts to this
special issue.
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